
Reata Pharmaceuticals RETA
Quartalsbericht 2023-Q1
hinzugefügt 10.05.2023
Reata Pharmaceuticals Current Ratio 2011-2026 | RETA
Current Ratio Jährlich Reata Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 3.49 | 6.12 | 2.8 | 1.46 | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 6.12 | 1.46 | 3.47 |
Current Ratio anderer Aktien in der Pharmaeinzelhändler
| Name | Current Ratio | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
1.61 | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
1.65 | - | - | $ 86.2 M | ||
|
MorphoSys AG
MOR
|
1.02 | - | 2.43 % | $ 254 M | ||
|
Akari Therapeutics, Plc
AKTX
|
2.45 | $ 5.12 | 11.55 % | $ 345 B | ||
|
Alterity Therapeutics Limited
ATHE
|
7.02 | $ 3.97 | 6.43 % | $ 9.55 B | ||
|
Akouos
AKUS
|
6.18 | - | 0.23 % | $ 488 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
1.19 | $ 320.13 | -3.98 % | $ 41.9 B | ||
|
Applied Molecular Transport
AMTI
|
2.31 | - | - | $ 10.1 M | ||
|
I-Mab
IMAB
|
8.96 | - | - | $ 866 M | ||
|
AlloVir
ALVR
|
2.84 | - | 4.14 % | $ 49.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
0.922 | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
1.34 | - | -13.47 % | $ 169 M | ||
|
Aligos Therapeutics
ALGS
|
2.53 | $ 7.66 | 3.23 % | $ 75.7 M | ||
|
Allakos
ALLK
|
3.26 | - | - | $ 28.6 M | ||
|
Ayala Pharmaceuticals
AYLA
|
6.43 | - | - | $ 7.46 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
2.68 | - | -18.52 % | $ 27.3 M | ||
|
Applied Therapeutics
APLT
|
0.762 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
2.35 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
1.21 | - | -13.39 % | $ 1.45 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
0.0929 | - | -2.5 % | $ 5.88 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.94 | $ 21.81 | 0.6 % | $ 1.02 B | ||
|
Burford Capital Limited
BUR
|
2.14 | $ 4.67 | -1.37 % | $ 766 M | ||
|
CymaBay Therapeutics
CBAY
|
3.05 | - | - | $ 3.45 B | ||
|
BioNTech SE
BNTX
|
7.95 | $ 102.12 | 2.66 % | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
1.04 | - | - | - | ||
|
Cabaletta Bio
CABA
|
3.11 | $ 3.52 | 3.53 % | $ 354 M | ||
|
Advaxis
ADXS
|
5.93 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
1.22 | - | 5.93 % | $ 314 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
2.76 | $ 3.08 | -4.94 % | $ 5.07 M | ||
|
AgeX Therapeutics
AGE
|
0.995 | - | -10.17 % | $ 12.2 K | ||
|
ContraFect Corporation
CFRX
|
0.636 | - | -5.16 % | $ 5.39 M | ||
|
Aeglea BioTherapeutics
AGLE
|
12.4 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
1.09 | $ 1.35 | -12.9 % | $ 347 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.79 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
0.827 | $ 4.26 | 0.47 % | $ 456 M | ||
|
Arcutis Biotherapeutics
ARQT
|
1.78 | $ 24.19 | -1.59 % | $ 3.08 B | ||
|
AIkido Pharma
AIKI
|
2.59 | - | 1.93 % | $ 17.4 M | ||
|
BioDelivery Sciences International
BDSI
|
2.37 | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
1.43 | $ 1.61 | 8.05 % | $ 428 M | ||
|
Aptose Biosciences
APTO
|
0.269 | - | -45.71 % | $ 1.2 M | ||
|
BeiGene, Ltd.
BGNE
|
2.14 | - | 0.49 % | $ 251 B | ||
|
Checkpoint Therapeutics
CKPT
|
0.372 | - | - | $ 169 M | ||
|
Caladrius Biosciences
CLBS
|
6.16 | - | -16.75 % | $ 25.8 M | ||
|
AVROBIO
AVRO
|
15.9 | - | 1083.1 % | $ 745 M | ||
|
Clearside Biomedical
CLSD
|
0.681 | - | - | $ 25.3 M | ||
|
Celldex Therapeutics
CLDX
|
10.4 | $ 33.86 | -0.03 % | $ 2.25 B | ||
|
bluebird bio
BLUE
|
1.46 | - | - | $ 546 M | ||
|
CNS Pharmaceuticals
CNSP
|
2.1 | $ 2.75 | - | $ 1.22 M |